|
 |
| |
| |
|
|
Sample Publications
J.R. Conejo-Garcia, F. Benencia, M.C. Courreges, P.A. Gimotty, E. Khang, R.J. Buckanovich, K.A. Frauwirth, L. Zhang, D. Katsaros, K. Sclienger, C.B.
Thompson, B. Levine, G. Coukos. LETAL promotes the survival and induces expansion of CD28(-) antitumor T cells through the NKG2D immunoreceptor in ovarian carcinoma. Cancer Res. 64:2175-82, 2004.
J.R. Conejo-Garcia, F. Benencia, M.C. Courreges, E. Kang, A. Mohamed-Hadley, R.J. Buckanovich, D. Holtz, A. Jenkins, H. Na, L. Zhang, D.S. Wagner, D.
Katsaros, R. Caroll, G. Coukos. Tumor-infiltrating dendritic cell
precursors recruited by beta-defensin contribute to vasculogenesis under the influence of VEGF. Nature Medicine, 10:942-9, 2004.
T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M.
Evdemon-Hogan, J.R. Conejo-Garcia, L. Zhang, M. Burow, Y. Zhu, S. Wei, I.
Kryczek, B. Daniel, A. Gordon, L. Myers, A. Lackner, M.L. Disis, K. Knuston, L. Chen, W. Zou. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine, 10:950-8, 2004.
L. Zhang, J.R. Conejo-Garcia, D. Katsaros, M. Massobrio, E. Kang, P. Gimotty, G. Regnani, A. Makrigiannakis, K. Schlienger, H. Gray, M. Liebman, S.C. Rubin, G. Coukos. Intratumoral T cells, Recurrence and Survival in Epithelial Ovarian Cancer. New Engl. J. Med., 348:201-211, 2003.
L. Zhang, N. Yang, J-R. Conejo-Garcia, A. Mohamed-Hadley, F. Benencia, S.C. Rubin, D. Allman, G. Coukos. Generation of a Syngeneic Mouse Model to Study the Effects of Vascular Endothelial Growth Factor in Ovarian Carcinoma. Am. J. Pathol. 161:2295-309, 2002.
G. Coukos, S. C. Rubin. Surgical Management of Ovarian Cancer. Oncol. Spectr, 350-361, 2001.
G. Coukos, S.C. Rubin. Gene Therapy of Ovarian Cancer. Oncology, 15:1197-1204, 2001.
G. Coukos, A. Makrigiannakis, S. Montas, L.R. Kaiser, I. Benjamin, S.M. Albelda, S.C. Rubin, K.L. Molnar-Kimber. Multi-Attenuated Herpes Simplex Virus-1 Mutant G207 Exerts Cytotoxicity Against Epithelial Ovarian Cancer but not Normal Mesothelium, and is Suitable for Intraperitoneal Oncolytic Therapy. Cancer Gene Ther. 7:275-283, 2000. |
|
|
|
| |
| TOP |
|
|
| The University of Pennsylvania Health System © 2007, The Trustees of the University of Pennsylvania. Unauthorized reproduction of this material is strictly prohibited.
|
| Disclaimer | Contact Webmaster |
|
|
|
|
